General Information of Drug (ID: DMSJOTL)

Drug Name
PF-06817024 Drug Info
Indication
Disease Entry ICD 11 Status REF
Atopic dermatitis EA80 Phase 1 [1]
Cross-matching ID
TTD Drug ID
DMSJOTL

Molecule-Related Drug Atlas

Molecule-Related Drug Atlas
Molecule Type:
DTT
Drug Status:
Clinical Trial Drug(s)
Drug(s) Targeting Cytokine unspecific (CYK)
Drug Name Drug ID Indication ICD 11 Highest Status REF
BMEC-1217B DMJNFI2 Allergic rhinitis CA08.0 Phase 1 [2]

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas

Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Cytokine unspecific (CYK) TTFTSHD NOUNIPROTAC Modulator [1]

References

1 Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)
2 ClinicalTrials.gov (NCT00425971) Safety Study of Anti-Asthma Agent BMEC-1217B. U.S. National Institutes of Health.